Perioperative Administration of Emend(®) (Aprepitant) at a Tertiary Care Children’s Hospital: A 12-Month Survey

INTRODUCTION: Aprepitant (Emend(®)) is a novel antiemetic agent that works through antagonism of neurokinin-1 (NK-1) receptors. To date, there are limited data regarding its use to prevent postoperative nausea and vomiting (PONV) in children. We retrospectively reviewed our initial 12-months experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanaparthi, Anuradha, Kukura, Sarah, Slenkovich, Natalie, AlGhamdi, Faris, Shafy, Shabana Z, Hakim, Mohammed, Tobias, Joseph D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885572/
https://www.ncbi.nlm.nih.gov/pubmed/31819673
http://dx.doi.org/10.2147/CPAA.S221736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885572/
https://www.ncbi.nlm.nih.gov/pubmed/31819673
http://dx.doi.org/10.2147/CPAA.S221736

Ejemplares similares